Related Experiment Videos
Coagulopathy in the trauma patient
1Oregon Health and Science University, Portland, Oregon 97239, USA. schreibm@ohsu.edu
Current Opinion in Critical Care
|November 18, 2005
Summary
Trauma disrupts the body's natural blood clotting balance, leading to either excessive bleeding or dangerous clots. New treatments show promise for improving survival in trauma patients with coagulopathy.
Area of Science:
- Trauma and Emergency Medicine
- Hematology
- Coagulation Science
Background:
- Homeostasis relies on a balance between hemostasis and fibrinolysis.
- Trauma disrupts this balance, causing hypocoagulable or hypercoagulable states.
- Coagulopathy in trauma patients presents complex challenges in management.
Purpose of the Study:
- To review the epidemiology and pathophysiology of coagulopathy after trauma.
- To discuss novel therapeutic strategies for traumatic coagulopathy.
Main Methods:
- Review of published reports from the past year.
- Analysis of factors affecting coagulation: hypothermia, acidosis, resuscitation fluids.
- Evaluation of emerging treatments for hemorrhage control.
Main Results:
- Coagulopathy in trauma is complex, leading to either hypocoagulable or hypercoagulable states.
- Standard coagulation tests are insufficient for guiding therapy.
- Recombinant factor VIIa is a popular but unproven therapy.
- New dressings show efficacy for local hemorrhage control.
Conclusions:
- Trauma-induced coagulopathy is a complex condition.
- Current coagulation parameters do not adequately guide treatment.
- Promising new agents offer potential for improved survival in coagulopathic trauma patients.